Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 70518-2789

2 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 70518-2789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

03aa71a-dcc0-4a41-815d-42293e69e7a8 (D03aa71a Dcc0 4a41 815d 42293e69e7a8)

03aa71a-dcc0-4a41-815d-42293e69e7a8 (D03aa71a Dcc0 4a41 815d 42293e69e7a8)
Chemical structure diagram of a compound showing aromatic rings and functional groups, including an acetoxy and hydrochloride (HCl) moiety. The structure includes nitrogen, sulfur, and oxygen atoms arranged in a complex molecular framework.*
FDA Label Image

Mm1 (Diltiazem HCl 120mg 70518 2789 00)

Mm1 (Diltiazem HCl 120mg 70518 2789 00)
Label for diltiazem HCl extended-release capsules, 120 mg strength, with a quantity of 30 capsules. The label shows the NDC number 70518-2789-00 and manufacturing by TWI Pharmaceuticals USA, Paramus, NJ. It includes storage instructions and repackaging information by RemedyRepack Inc., Indiana, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.